JP2023520714A5 - - Google Patents
Info
- Publication number
- JP2023520714A5 JP2023520714A5 JP2022560943A JP2022560943A JP2023520714A5 JP 2023520714 A5 JP2023520714 A5 JP 2023520714A5 JP 2022560943 A JP2022560943 A JP 2022560943A JP 2022560943 A JP2022560943 A JP 2022560943A JP 2023520714 A5 JP2023520714 A5 JP 2023520714A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- hereinafter referred
- loop
- peptide ligand
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005744P | 2020-04-06 | 2020-04-06 | |
| US63/005,744 | 2020-04-06 | ||
| PCT/GB2021/050846 WO2021205161A1 (en) | 2020-04-06 | 2021-04-06 | Bicyclic peptide ligands specific for tslp |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520714A JP2023520714A (ja) | 2023-05-18 |
| JP2023520714A5 true JP2023520714A5 (enExample) | 2024-04-11 |
Family
ID=75539693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560943A Pending JP2023520714A (ja) | 2020-04-06 | 2021-04-06 | Ｔｓｌｐに特異的な二環式ペプチドリガンド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11866518B2 (enExample) |
| EP (1) | EP4132481A1 (enExample) |
| JP (1) | JP2023520714A (enExample) |
| CN (1) | CN115768456A (enExample) |
| WO (1) | WO2021205161A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201918557D0 (en) * | 2019-12-16 | 2020-01-29 | Bicycle Tx Ltd | Bicyclic peptide ligands specific for IL-17 |
| WO2021205161A1 (en) | 2020-04-06 | 2021-10-14 | Bicycletx Limited | Bicyclic peptide ligands specific for tslp |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002000723A2 (en) * | 2000-06-28 | 2002-01-03 | Whitehead Institute For Biomedical Research | Thymic stromal lymphopoietin receptor molecules and uses thereof |
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| ES2428869T3 (es) | 2005-01-24 | 2013-11-12 | Pepscan Systems B.V. | Compuestos de unión, compuestos inmunógenos y peptidomiméticos |
| JP6074574B2 (ja) * | 2008-02-05 | 2017-02-08 | バイシクル セラピューティクス リミテッド | 方法及び組成物 |
| GB201306623D0 (en) * | 2013-04-11 | 2013-05-29 | Bicycle Therapeutics Ltd | Modulation of structured polypeptide specificity |
| KR101843248B1 (ko) * | 2015-03-17 | 2018-03-29 | 고려대학교 세종산학협력단 | 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물 |
| EA038332B1 (ru) * | 2015-09-09 | 2021-08-10 | Новартис Аг | Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул |
| AR111380A1 (es) * | 2017-04-12 | 2019-07-03 | Amgen Inc | Tratamiento para el asma con anticuerpo anti-tslp |
| WO2021205161A1 (en) | 2020-04-06 | 2021-10-14 | Bicycletx Limited | Bicyclic peptide ligands specific for tslp |
-
2021
- 2021-04-06 WO PCT/GB2021/050846 patent/WO2021205161A1/en not_active Ceased
- 2021-04-06 US US17/223,244 patent/US11866518B2/en active Active
- 2021-04-06 EP EP21719210.3A patent/EP4132481A1/en not_active Withdrawn
- 2021-04-06 CN CN202180038689.5A patent/CN115768456A/zh active Pending
- 2021-04-06 JP JP2022560943A patent/JP2023520714A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518210A5 (enExample) | ||
| JP2022517040A5 (enExample) | ||
| JP5680661B2 (ja) | Ｉｌ−２に由来する免疫調節ポリペプチド並びに癌及び慢性感染症の治療におけるその使用 | |
| JP2022514255A5 (enExample) | ||
| JP2022518695A5 (enExample) | ||
| JP2022514687A5 (enExample) | ||
| JP2010518079A5 (enExample) | ||
| JP2010518006A5 (enExample) | ||
| US20130205416A1 (en) | Anti-viral agent | |
| JP6158097B2 (ja) | 炎症を抑制するためのペプチド | |
| JP2022515720A5 (enExample) | ||
| JP2021530570A (ja) | てんかん、発作および中枢神経系障害を治療するための経口抗炎症性ペプチド | |
| KR102806029B1 (ko) | 사이클릭 폴리펩타이드, 그것의 제조 방법 및 치료학적 용도 | |
| JP2914672B2 (ja) | Ｂｓｆ▲下２▼アンタゴニスト | |
| JP2018531284A6 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| JP6357470B2 (ja) | 改良されたｃｄ３１ペプチド | |
| US12552848B2 (en) | Hydrochloride salts of C5a receptor agonist peptides | |
| AU2003209030B2 (en) | Anti-infarction molecules | |
| US12624072B2 (en) | Engineering broadly reactive human notch ligands as novel tools for biomedical applications | |
| JP2022515721A5 (enExample) | ||
| CA2999792A1 (en) | Use of human derived immunosuppressive proteins and peptides as medicaments | |
| US8110552B2 (en) | Antagonists against interaction of PF4 and RANTES | |
| JPWO2002092121A1 (ja) | 新規な神経変性疾患治療剤 | |
| JPWO2018038168A1 (ja) | ヘマグルチニン結合ペプチド、および、これを含むインフルエンザウイルス感染症の予防・治療薬 | |
| US12565523B2 (en) | Structure-guided engineering of peptide-based NLRP3 inflammasome inhibitors for myelodysplastic syndromes (MDS) |